Aptevo Therapeutics Inc. Operating Leases, Rent Expense
Aptevo Therapeutics Inc. (APVO) reported Operating Leases, Rent Expense of $1.20 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-03-18
- Aptevo Therapeutics Inc. operating leases, rent expense for fiscal 2018 was $1.20M, a 29.41% decline from fiscal 2017.
- Aptevo Therapeutics Inc. operating leases, rent expense for fiscal 2017 was $1.70M, a 5.56% decline from fiscal 2016.
- Aptevo Therapeutics Inc. operating leases, rent expense for fiscal 2016 was $1.80M, a 0.00% change from fiscal 2015.
- Aptevo Therapeutics Inc. operating leases, rent expense for fiscal 2015 was $1.80M.
| Period end | Operating Leases, Rent Expense 12 month |
|---|---|
| 2018-12-31 | $1.20M 10-K · filed 2019-03-18 |
| 2017-12-31 | $1.70M 10-K · filed 2019-03-18 |
| 2016-12-31 | $1.80M 10-K · filed 2018-03-13 |
| 2015-12-31 | $1.80M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |